Trials / Completed
CompletedNCT00196235
Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Diabetes Mellitus
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 650 (planned)
- Sponsor
- Deutsches Herzzentrum Muenchen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to evaluate the performance of established and new risk predictors in predicting mortality in post-infarction patients suffering from diabetes mellitus
Conditions
Timeline
- Start date
- 1995-01-01
- First posted
- 2005-09-20
- Last updated
- 2018-03-12
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00196235. Inclusion in this directory is not an endorsement.